Literature DB >> 26919894

The functional significance of the last 5 residues of the C-terminus of cardiac troponin I.

Jennifer E Gilda1, Qian Xu1, Margaret E Martinez2, Susan T Nguyen1, P Bryant Chase2, Aldrin V Gomes3.   

Abstract

The C-terminal region of cardiac troponin I (cTnI) is known to be important in cardiac function, as removal of the last 17 C-terminal residues of human cTnI has been associated with myocardial stunning. To investigate the C-terminal region of cTnI, three C-terminal deletion mutations in human cTnI were generated: Δ1 (deletion of residue 210), Δ3 (deletion of residues 208-210), and Δ5 (deletion of residues 206-210). Mammalian two-hybrid studies showed that the interactions between cTnI mutants and cardiac troponin C (cTnC) or cardiac troponin T (cTnT) were impaired in Δ3 and Δ5 mutants when compared to wild-type cTnI. Troponin complexes containing 2-[4'-(iodoacetamido) anilino] naphthalene-6-sulfonic acid (IAANS) labeled cTnC showed that the troponin complex containing cTnI Δ5 had a small increase in Ca(2+) affinity (P < 0.05); while the cTnI Δ1- and Δ3 troponin complexes showed no difference in Ca(2+) affinity when compared to wild-type troponin. In vitro motility assays showed that all truncation mutants had increased Ca(2+) dependent motility relative to wild-type cTnI. These results suggest that the last 5 C-terminal residues of cTnI influence the binding of cTnI with cTnC and cTnT and affect the Ca(2+) dependence of filament sliding, and demonstrate the importance of this region of cTnI.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium; Heart; In vitro motility assay; Mammalian two-hybrid; Troponin I; Unloaded filament sliding

Mesh:

Substances:

Year:  2016        PMID: 26919894      PMCID: PMC4899223          DOI: 10.1016/j.abb.2016.02.023

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  60 in total

1.  Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy.

Authors:  Rosalyn Lang; Aldrin V Gomes; Jiaju Zhao; Philippe R Housmans; Todd Miller; James D Potter
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

2.  Preparation of myosin and its subfragments from rabbit skeletal muscle.

Authors:  S S Margossian; S Lowey
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  Expanding the range of free calcium regulation in biological solutions.

Authors:  David Dweck; Avelino Reyes-Alfonso; James D Potter
Journal:  Anal Biochem       Date:  2005-10-11       Impact factor: 3.365

4.  Calcium-regulated conformational change in the C-terminal end segment of troponin I and its binding to tropomyosin.

Authors:  Zhiling Zhang; Shirin Akhter; Steven Mottl; Jian-Ping Jin
Journal:  FEBS J       Date:  2011-08-16       Impact factor: 5.542

5.  Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart.

Authors:  Aldrin V Gomes; Georgianna Guzman; Jiaju Zhao; James D Potter
Journal:  J Biol Chem       Date:  2002-07-01       Impact factor: 5.157

6.  Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling.

Authors:  Brenda Schoffstall; Aya Kataoka; Amanda Clark; P Bryant Chase
Journal:  J Pharmacol Exp Ther       Date:  2004-08-11       Impact factor: 4.030

7.  The C terminus of cardiac troponin I stabilizes the Ca2+-activated state of tropomyosin on actin filaments.

Authors:  Agnieszka Galińska; Victoria Hatch; Roger Craig; Anne M Murphy; Jennifer E Van Eyk; C-L Albert Wang; William Lehman; D Brian Foster
Journal:  Circ Res       Date:  2009-12-24       Impact factor: 17.367

8.  CORRIGENDUM: Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.

Authors:  Ahmed A Alfares; Melissa A Kelly; Gregory McDermott; Birgit H Funke; Matthew S Lebo; Samantha B Baxter; Jun Shen; Heather M McLaughlin; Eugene H Clark; Larry J Babb; Stephanie W Cox; Steven R DePalma; Carolyn Y Ho; J G Seidman; Christine E Seidman; Heidi L Rehm
Journal:  Genet Med       Date:  2015-04       Impact factor: 8.822

9.  Disease-related cardiac troponins alter thin filament Ca2+ association and dissociation rates.

Authors:  Bin Liu; Svetlana B Tikunova; Kristopher P Kline; Jalal K Siddiqui; Jonathan P Davis
Journal:  PLoS One       Date:  2012-06-04       Impact factor: 3.240

10.  Structural dynamics of troponin I during Ca2+-activation of cardiac thin filaments: a multi-site Förster resonance energy transfer study.

Authors:  Hui Wang; Joseph M Chalovich; Gerard Marriott
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more
  9 in total

1.  Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.

Authors:  Hanna J Tadros; Chelsea S Life; Gustavo Garcia; Elisa Pirozzi; Edward G Jones; Susmita Datta; Michelle S Parvatiyar; P Bryant Chase; Hugh D Allen; Jeffrey J Kim; Jose R Pinto; Andrew P Landstrom
Journal:  J Mol Cell Cardiol       Date:  2020-04-09       Impact factor: 5.000

2.  Improving the sensitivity of traditional Western blotting via Streptavidin containing Poly-horseradish peroxidase (PolyHRP).

Authors:  Manish Mishra; Shuchita Tiwari; Anita Gunaseelan; Dongyang Li; Bruce D Hammock; Aldrin V Gomes
Journal:  Electrophoresis       Date:  2019-05-09       Impact factor: 3.535

3.  Myofilament modulation of contraction.

Authors:  Brandon J Biesiadecki
Journal:  Arch Biochem Biophys       Date:  2016-05-06       Impact factor: 4.013

4.  Role of cardiac troponin I carboxy terminal mobile domain and linker sequence in regulating cardiac contraction.

Authors:  Nancy L Meyer; P Bryant Chase
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

5.  C-terminal troponin-I residues trap tropomyosin in the muscle thin filament blocked-state.

Authors:  William Lehman; Elumalai Pavadai; Michael J Rynkiewicz
Journal:  Biochem Biophys Res Commun       Date:  2021-03-11       Impact factor: 3.575

6.  Potential impacts of the cardiac troponin I mobile domain on myofilament activation and relaxation.

Authors:  Jenette G Creso; Stuart G Campbell
Journal:  J Mol Cell Cardiol       Date:  2021-02-26       Impact factor: 5.763

7.  Amino Acid Changes at Arginine 204 of Troponin I Result in Increased Calcium Sensitivity of Force Development.

Authors:  Susan Nguyen; Rylie Siu; Shannamar Dewey; Ziyou Cui; Aldrin V Gomes
Journal:  Front Physiol       Date:  2016-11-15       Impact factor: 4.566

Review 8.  Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics.

Authors:  Lucas K Keyt; Jason M Duran; Quan M Bui; Chao Chen; Michael I Miyamoto; Jorge Silva Enciso; Jil C Tardiff; Eric D Adler
Journal:  Front Cardiovasc Med       Date:  2022-09-07

9.  Cardiac troponins may be irreversibly modified by glycation: novel potential mechanisms of cardiac performance modulation.

Authors:  Johannes V Janssens; Brendan Ma; Margaret A Brimble; Jennifer E Van Eyk; Lea M D Delbridge; Kimberley M Mellor
Journal:  Sci Rep       Date:  2018-10-31       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.